Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $56.07 million. The enterprise value is $56.13 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IBO has 107.82 million shares outstanding. The number of shares has increased by 392.17% in one year.
| Current Share Class | 107.82M |
| Shares Outstanding | 107.82M |
| Shares Change (YoY) | +392.17% |
| Shares Change (QoQ) | +20.07% |
| Owned by Insiders (%) | 2.83% |
| Owned by Institutions (%) | 3.45% |
| Float | 11.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,439.83 |
| Forward PS | n/a |
| PB Ratio | 5.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,439.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.63 |
Financial Efficiency
Return on equity (ROE) is -119.66% and return on invested capital (ROIC) is -22.62%.
| Return on Equity (ROE) | -119.66% |
| Return on Assets (ROA) | -18.68% |
| Return on Invested Capital (ROIC) | -22.62% |
| Return on Capital Employed (ROCE) | -36.03% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $19,500 |
| Profits Per Employee | -$6.43M |
| Employee Count | 2 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | -2.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.45% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.56 |
| Relative Strength Index (RSI) | 31.43 |
| Average Volume (20 Days) | 50,178 |
Short Selling Information
The latest short interest is 1.01 million, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 1.01M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 0.94% |
| Short % of Float | 8.85% |
| Short Ratio (days to cover) | 8.30 |
Income Statement
In the last 12 months, IBO had revenue of $39,000 and -$12.86 million in losses. Loss per share was -$0.23.
| Revenue | 39,000 |
| Gross Profit | -385,000 |
| Operating Income | -5.55M |
| Pretax Income | -15.46M |
| Net Income | -12.86M |
| EBITDA | -4.40M |
| EBIT | -5.55M |
| Loss Per Share | -$0.23 |
Full Income StatementBalance Sheet
The company has $20,000 in cash and n/a in debt, with a net cash position of $20,000 or $0.00 per share.
| Cash & Cash Equivalents | 20,000 |
| Total Debt | n/a |
| Net Cash | 20,000 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 14.71M |
| Book Value Per Share | 0.11 |
| Working Capital | -1.31M |
Full Balance SheetCash Flow
| Operating Cash Flow | -1.67M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.15M |
| Net Borrowing | 373,000 |
| Free Cash Flow | -1.67M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -14,228.21% |
| Pretax Margin | -39,630.77% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
